DeepMed Research

Aetion, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

CARE Initiative: Real-world Emulation of the PALOMA-2 Trial

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Palbociclib
Drug: Letrozole

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 724

Registration Number: NCT06607601

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Completed

Conditions: Metastatic Nonsmall Cell Lung Cancer

Interventions: Drug: Pemetrexed
Drug: Pembrolizumab
Drug: Carboplatin
Drug: Cisplatin

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 851

Registration Number: NCT06607393

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]

Completed

Conditions: Metastatic Non Small Cell Lung Cancer

Interventions: Drug: Pembrolizumab
Drug: Pemetrexed
Drug: Cisplatin
Drug: Carboplatin

First Posted Date: 2024-09-05

Last Posted Date: 2024-09-05

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 304

Registration Number: NCT06585189

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

Completed

Conditions: Non-small Cell Lung Cancer
Metastatic Lung Cancer

Interventions: Drug: Pembrolizumab + Pemetrexed-Platinum
Drug: Pemetrexed-Platinum

First Posted Date: 2023-06-18

Last Posted Date: 2023-09-13

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 1854

Registration Number: NCT05908799

Locations: 🇺🇸
Aetion, Boston, Massachusetts, United States

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments

Active, not recruiting

Conditions: COVID-19

Interventions: Drug: Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)

First Posted Date: 2022-12-06

Last Posted Date: 2023-09-08

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 3000

Registration Number: NCT05638932

Locations: 🇺🇸
Aetion, Inc., New York, New York, United States

Dexamethasone and COVID-19 Inpatient Mortality

Completed

Conditions: Coronavirus

Interventions: Drug: Dexamethasone Oral

First Posted Date: 2021-06-15

Last Posted Date: 2023-04-18

Lead Sponsor: Aetion, Inc.

Target Recruit Count: 14105

Registration Number: NCT04926571

Locations: 🇺🇸
Aetion, Inc., New York, New York, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy